Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan in Previously Treated Advanced Sarcomas
NCT00003719Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Jul 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in soft tissue sarcoma (STS), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
irinotecan
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00003719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003719.